ALHC — Alignment Healthcare Income Statement
0.000.00%
Last trade - 00:00
- $2.27bn
- $2.12bn
- $1.82bn
- 33
- 36
- 92
- 52
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 757 | 959 | 1,168 | 1,434 | 1,824 |
Cost of Revenue | |||||
Gross Profit | 95.6 | 166 | 129 | 184 | 201 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 786 | 964 | 1,346 | 1,565 | 1,951 |
Operating Profit | -29.5 | -5.26 | -178 | -131 | -128 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -44.7 | -22.9 | -195 | -149 | -148 |
Provision for Income Taxes | |||||
Net Income After Taxes | -44.7 | -22.9 | -195 | -150 | -148 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -44.7 | -22.9 | -195 | -150 | -148 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -44.7 | -22.9 | -195 | -150 | -148 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.239 | -0.122 | -1.1 | -0.81 | -0.784 |
Dividends per Share |